对多支血管的冠心病选择经皮血管成形术或者外科手术的血管成形术.pptVIP

Percutaneous or Surgical Revascularization for Multivessel Coronary Artery Disease?; ;Invasive Therapies;12-Year Survival in Patients with CAD;12-Year Survival in Patients with CAD;Clinical Presentation;Extension of Survival with CABG vs Medical Therapy After 10 Years;CABG vs Stenting for MVD Meta-Analysis of ARTS, ERACI-II, MASS-II and SOS;Increased Likelihood of Restenosis Lesion/Patient Subsets;Hazard ratio 95% CI;CABG vs Drug-Eluting Stents in Multivessel Coronary DiseaseA Meta-Analysis on 24,268 Patients;;SYNTAX Inclusion Criteria;;Cumulative rate (%);SYNTAX CABG/PCI Registries;SYNTAX S